Tablet obtained by direct compression comprising...

Details Tablet obtained by direct compression comprising... Tablet obtained by direct compression comprising...

2007-04-03

2007-04-03

Woodward, Michael P. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

Reexamination Certificate

active

10257958

ABSTRACT:
A tablet, obtainable by direct comprising the active ingredient 4-amino-1-hydroxybutylidene-1,1-bis-phosphonic (alendronic) acid or its pharmaceutically acceptable salts in an amount of 5 to 140 mg, based on the pure acid, a dry binder, a disintegrating agent, a lubricant, the tablet comprising, as the diluent, a combination of at least two diluents except lactose.

REFERENCES:
patent: 5650168 (1997-07-01), Preis et al.
patent: 5853759 (1998-12-01), Katdare et al.
patent: 6455572 (2002-09-01), Day et al.
patent: 94 12200 (1994-06-01), None
patent: WO 94 12200 (1994-06-01), None
patent: 98 42379 (1998-10-01), None

Affiliated with

Also associated with

Rating

Tablet obtained by direct compression comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tablet obtained by direct compression comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tablet obtained by direct compression comprising... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3729316